Exagen Inc. XGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$20.17M-30.0% | -$19.95M-32.0% | -$19.04M-12.5% | -$16.98M+1.9% | -$15.51M+19.9% | ||
| $2.4M+47.3% | $2.16M+22.4% | $1.89M-9.9% | $1.51M-45.4% | $1.63M-48.9% | ||
| $469K+195% | $378K+145% | $289K+94.0% | $197K+27.9% | $159K+5.3% | ||
| —— | —— | —— | —— | —— | ||
| -$230K-111% | $42K-86.4% | $1.79M+432% | -$449K-145% | $2.19M+935% | ||
| $112K— | $251K— | —— | —— | —— | ||
| -$892K— | -$792K— | -$507K— | —— | —— | ||
| $26K— | -$147K— | -$217K— | -$354K— | —— | ||
| —— | —— | $641K— | $1.02M— | $876K— | ||
| -$1.13M-12.4% | -$1.1M-12.3% | -$1.06M-10.5% | -$1.03M-5.6% | -$1M-0.9% | ||
| —— | —— | —— | -$15.73M— | -$15.27M— | ||
| $756K+39.5% | $641K+24.5% | $743K+56.4% | $615K+86.4% | $542K+4.6% | ||
| —— | —— | —— | —— | $6K— | ||
| -$747K-39.4% | -$626K-21.6% | -$737K-62.7% | -$609K-97.7% | -$536K-8.5% | ||
| $653K+1,455% | $592K— | $427K— | $265K— | $42K— | ||
| —— | —— | —— | $18.78M— | $198K— | ||
| $593K+34.5% | $494K+0.8% | $424K-20.7% | $362K-39.2% | $441K-31.8% | ||
| $804K+1,137% | $869K— | $869K— | $670K— | $65K— | ||
| $24.82M+4,059% | $24.82M+3,843% | $24.6M+3,789% | $21.53M+3,392% | -$627K+94.1% | ||
| —— | —— | $13.62M— | $5.55M— | -$16.07M— | ||
| $3.44M+104% | $2.99M+73.8% | $2.52M+47.5% | $2.07M+21.1% | $1.69M-2.0% | ||
| $469K+195% | $378K+145% | $289K+94.0% | $197K+27.9% | $159K+5.3% | ||
| $1.44M— | $777K— | $500K— | $200K— | —— | ||
| $2.28M+33.5% | $2.12M+22.9% | $1.93M+6.4% | $1.74M-12.8% | $1.71M-17.7% | ||
| $112K— | $251K— | —— | —— | —— | ||
| -$1.13M-12.4% | -$1.1M-12.3% | -$1.06M-10.5% | -$1.03M-5.6% | -$1M-0.9% | ||
| —— | —— | $1.09M+51.7% | $1.17M+12.7% | $2.35M+78,233% | ||
| —— | —— | —— | —— | —— | ||
| $26K— | -$147K— | -$217K— | -$354K— | —— | ||
| —— | —— | —— | —— | $6K— | ||
| $593K+34.5% | $494K+0.8% | $424K-20.7% | $362K-39.2% | $441K-31.8% | ||
| $804K— | $869K— | $869K— | $670K— | —— | ||
| $495K— | $398K— | —— | —— | —— | ||
| $653K+58.1% | $592K+59.6% | $532K+61.2% | $473K+63.1% | $413K+62.6% | ||
| -$79K-109% | $25K-96.6% | $714K— | $697K— | $906K— | ||
| —— | $3.28M— | $2.46M— | $1.64M— | $819.75K— | ||
| —— | —— | $3.11M— | $438K— | $0— | ||
| —— | —— | $641K— | $1.02M— | $876K— | ||
| -$1.13M-12.4% | -$1.1M-12.3% | -$1.06M-10.5% | -$1.03M-5.6% | -$1M-0.9% | ||
| $2.55M+277% | $3.23M— | $3.23M— | $682K— | $677K— | ||
| —— | —— | —— | -$16.2M— | -$15.67M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
